Sun Pharmaceutical Industries informs about company updates

20 Dec 2016 Evaluate

Sun Pharmaceutical Industries has informed that one of the Company’s wholly-owned subsidiaries has voluntarily requested the USFDA to withdraw approval for 28 Abbreviated New Drug Applications (ANDAs). These older drug products belong to erstwhile Ranbaxy Laboratories and are not being marketed in the US since 2008.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1610.15 -29.15 (-1.78%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×